Merck / Squibb / Abbott Laboratories / Bristol-Myers Squibb / Johnson & Johnson / STI / Pfizer / STIs / Abbott Labs / Tibotec Therapeutics / Schering / /
Continent
Africa / Asia / South America / /
Country
Thailand / United States / /
Currency
USD / / /
Event
FDA Phase / / /
IndustryTerm
pharmaceutical industry / insurance / HIV Therapy / healthcare benefits / metal needle / AIDS Treatment / earlier web address / insurance payers / HIV care / pharmaceutical / HIV treatment / health insurance / obvious solution / pharmaceutical products / good product / /
MedicalCondition
HIV / acute illness / people suffering disease / role inflammation / earlier opportunistic infection / liver disease / lipodystrophy / serious treatment fatigue / certain major infections / AIDS / coronary artery disease / HIV/AIDS / heart disease / treatment fatigue / HIV infection / common opportunistic infections / Opportunistic Infections / disease / kidney disease / hyperlipidemia / heart attack / long-term infection / HIV disease / /
MedicalTreatment
salvage therapy / experimental therapy / drug therapy / /
Organization
Federal Trade Commission / US Federal Reserve / FDA / Data Safety and Monitoring Board / Food and Drug Administration / Fair Pricing Coalition / Congress / /
Person
Glenn R. Mattes / / /
Position
President / non-nucleoside RT / first non-nucleoside RT / /
P.I. Perspective June 2006, Issue #41 Information, Inspiration and Advocacy for People Living with HIV/AIDS